Y0002441

Cabazitaxel for system suitability CRS

European Pharmacopoeia (EP) Reference Standard

• 別名: Cabazitaxel acetone
• 実験式（ヒル表記法）: C₄₅H₅₇NO₁₄·C₃H₆O
• CAS番号: 1426815-65-7
• 分子量: 894.01
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• メーカー／製品名: EDQM
• アプリケーション: pharmaceutical
• 保管温度: 2-8°C
• SMILES記法: N([C@H]([C@@H](O)C(=O)O[C@H]2C[C@]3([C@H]([C@@H]5[C@]6([C@H](OC6)C[C@@H]([C@]5(C(=O)[C@@H](C(=C2C)C3(C)C)OC)C)OC)OC(=O)C)OC(=O)c4ccccc4)O)c1ccccc1)C(=O)OC(C)(C)C.O=C(C)C
• InChI Key: JXGFNOAMBPABCK-JVXKREHESA-N

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. Compendial materials should be used for the purpose described in the appropriate monograph unless otherwise authorized by the National Competent Authority. For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

e.g. pharmaceutical (small molecule)

包装

Unit quantity: 10mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit EDQM reference substance catalogue.

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS08,GHS07
• シグナルワード: Warning
• 危険有害性情報: H302,H315,H341,H361fd,H373
• 注意書き: P202 - P260 - P264 - P301 + P312 - P302 + P352 - P308 + P313
• 危険有害性の分類: Acute Tox. 4 Oral - Muta. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 2
• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 2
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable